4BIO Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
12
- Investments
-
41
- Portfolio
-
15
- Exits
-
15
4BIO Capital General Information
Company Description
Founded in 2015, 4BIO Capital is a biotech venture capital firm based in London, United Kingdom. The firm builds and invests in companies developing advanced and emerging therapeutics.
Business Details
Website
www.4biocapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 20 North Audley Street
- London W1K 6WE
- England, United Kingdom
4BIO Capital Investments (41)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Actithera | 09-Jul-2025 | Early Stage VC | Biotechnology | Pre-Clinical Trials | ||
| NV Therapeutics | 13-Mar-2025 | Biotechnology | Startup | |||
| March Biosciences | 03-Jan-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Cytospire Therapeutics | 01-Oct-2024 | Biotechnology | Startup | |||
| Trogenix | 16-Aug-2024 | Biotechnology | Generating Revenue | |||
| Hornet Therapeutics | 23-May-2024 | Biotechnology | Clinical Trials - General | |||
| ViaNautis | 06-Jul-2023 | Biotechnology | Generating Revenue | |||
| Ray Therapeutics | 15-May-2023 | Drug Discovery | Clinical Trials - General | |||
| Ascend (Biotechnology) | 08-May-2023 | Early Stage VC | Biotechnology | Startup | ||
| Carisma Therapeutics | 07-Mar-2023 | PIPE | Drug Discovery | Generating Revenue/Not Profitable |
4BIO Capital Exits (15)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Araris | 31-Mar-2025 | Merger/Acquisition | |
| Fate Therapeutics | 20-Mar-2024 | ||
| Redpin Therapeutics | 16-Nov-2022 | ||
| Dicerna Pharmaceuticals | 28-Dec-2021 | ||
| Prevail Therapeutics | 22-Jan-2021 | ||
| ADC Therapeutics | 15-May-2020 | ||
| Spark Therapeutics | 17-Dec-2019 | ||
| NightstaRx | 07-Jun-2019 | ||
| uniQure | 01-Jun-2019 | Merger/Acquisition | |
| Atara Biotherapeutics | 01-Jan-2019 | Secondary Transaction - Private |
4BIO Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
4BIO Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
4BIO Capital Co-Investors (99)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Abingworth | 3 |
|
|
||
| Arkin Capital |
|
|
|||
| Deerfield Management |
|
|
|||
| MRL Ventures Fund |
|
|
|||
| UPMC Enterprises |
|
|
4BIO Capital FAQs
-
What is 4BIO Capital?
Founded in 2015, 4BIO Capital is a biotech venture capital firm based in London, United Kingdom.
-
When was 4BIO Capital founded?
4BIO Capital was founded in 2015.
-
Where is 4BIO Capital headquartered?
4BIO Capital is headquartered in London, United Kingdom.
-
What is 4BIO Capital's total asset value?
4BIO Capital has around in total assets under management.
-
How many investments has 4BIO Capital made?
4BIO Capital has made 41 investments.
-
What has 4BIO Capital invested in?
4BIO Capital has made numerous investments in companies like Actithera, NV Therapeutics, and March Biosciences within the Biotechnology and Drug Discovery industries.
-
What has 4BIO Capital invested in recently?
4BIO Capital's latest investment was on 09-Jul-2025 in Actithera, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
